Pharma giant Cipla already has stocks of its Tamiflu equivalent Antiflu and can easily make more available if the demand grows

If you have been concerned about hospitals running out of Tamiflu, the H1N1 cure, breathe easy.

The pharmaceutical giant Cipla has said they already have a healthy stock of Oseltamivir, which they call Antiflu, and can produce a million more units in six weeks.

Speaking to MiD DAY on the sidelines of a conference on swine flu, Cipla medical director Dr Jaideep Gogtay said they were upping production of the drug and were in a position to provide the promised units if the government asked for it.

Alternative for tamiflu? Cipla says its Oseltamivir or Antiflu can be used to treat the H1N1 virus Read More Read Next Story Swine Flu kits only for BMC hospitals› Trending Stories Latest Photos Latest Videos Latest Web Stories ADVERTISEMENT Mid-Day Fast ADVERTISEMENT ADVERTISEMENT